These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 9726717)

  • 21. Effect of addition of inhaled salmeterol to the treatment of moderate-to-severe asthmatics uncontrolled on high-dose inhaled steroids. European Respiratory Study Group.
    Faurschou P; Steffensen I; Jacques L
    Eur Respir J; 1996 Sep; 9(9):1885-90. PubMed ID: 8880107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics.
    Nielsen LP; Pedersen B; Faurschou P; Madsen F; Wilcke JT; Dahl R
    Respir Med; 1999 Dec; 93(12):863-8. PubMed ID: 10653047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.
    Simons FE; Gerstner TV; Cheang MS
    Pediatrics; 1997 May; 99(5):655-9. PubMed ID: 9113940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential masking effects of salmeterol on airway inflammation in asthma.
    Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR
    Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute bronchodilatory effect of salmeterol on methacholine-induced bronchoconstriction in childhood asthma.
    Baki A; Karagüzel G
    Acta Paediatr Jpn; 1998 Apr; 40(2):135-7. PubMed ID: 9581303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours.
    Derom EY; Pauwels RA; Van der Straeten ME
    J Allergy Clin Immunol; 1992 Apr; 89(4):811-5. PubMed ID: 1560164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases.
    Murray JJ; Church NL; Anderson WH; Bernstein DI; Wenzel SE; Emmett A; Rickard KA
    Allergy Asthma Proc; 1999; 20(3):173-80. PubMed ID: 10389550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of inhaled salmeterol on sulfur dioxide-induced bronchoconstriction in asthmatic subjects.
    Gong H; Linn WS; Shamoo DA; Anderson KR; Nugent CA; Clark KW; Lin AE
    Chest; 1996 Nov; 110(5):1229-35. PubMed ID: 8915226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids.
    Vermetten FA; Boermans AJ; Luiten WD; Mulder PG; Vermue NA
    J Asthma; 1999; 36(1):97-106. PubMed ID: 10077139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
    Currie GP; Syme-Grant NJ; McFarlane LC; Carey FA; Lipworth BJ
    Allergy; 2003 Jul; 58(7):602-7. PubMed ID: 12823118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge.
    Giannini D; Bacci E; Dente FL; Di Franco A; Vagaggini B; Testi R; Paggiaro P
    Chest; 1999 Mar; 115(3):629-34. PubMed ID: 10084467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial.
    Kelsen SG; Church NL; Gillman SA; Lanier BQ; Emmett AH; Rickard KA; Anderson WH
    J Asthma; 1999 Dec; 36(8):703-15. PubMed ID: 10609625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study.
    Wilding P; Clark M; Thompson Coon J; Lewis S; Rushton L; Bennett J; Oborne J; Cooper S; Tattersfield AE
    BMJ; 1997 May; 314(7092):1441-6. PubMed ID: 9167559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
    N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.
    Wechsler ME; Kunselman SJ; Chinchilli VM; Bleecker E; Boushey HA; Calhoun WJ; Ameredes BT; Castro M; Craig TJ; Denlinger L; Fahy JV; Jarjour N; Kazani S; Kim S; Kraft M; Lazarus SC; Lemanske RF; Markezich A; Martin RJ; Permaul P; Peters SP; Ramsdell J; Sorkness CA; Sutherland ER; Szefler SJ; Walter MJ; Wasserman SI; Israel E;
    Lancet; 2009 Nov; 374(9703):1754-64. PubMed ID: 19932356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unaltered perception of dyspnoea during treatment with long-acting beta2-agonists.
    van der Woude HJ; Aalbers R
    Eur Respir J; 2001 Aug; 18(2):269-71. PubMed ID: 11529283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained protection against distilled water provocation by a single dose of salmeterol in patients with asthma.
    Bootsma GP; Dekhuijzen PN; Festen J; Lammers JW; Mulder PG; van Herwaarden CL
    Eur Respir J; 1997 Oct; 10(10):2230-6. PubMed ID: 9387945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.